Table 1.
The pattern of mutation and clinical symptoms in FV deficiency family.
| Genotype | Patient 1 | Patient 2 | Father | Mother | |
|---|---|---|---|---|---|
| Exon 3 Asp68His | Heterozygote gac → cac | Heterozygote | Heterozygote | Heterozygote | |
| Exon 8 Met385Thr | Heterozygote atg → acg | Heterozygote | Heterozygote | Heterozygote | |
| Exon13 Asn789Thr | Heterozygote aac → acc | Heterozygote | Heterozygote | Heterozygote | |
| Exon13 Lys830Arg | Heterozygote aaa → aga | Heterozygote | Heterozygote | Heterozygote | |
| Exon13 His837Arg | Heterozygote cat → cgt | Heterozygote | Heterozygote | Heterozygote | |
| Exon13 Lys897Glu | Heterozygote aag → gag | Heterozygote | Heterozygote | Heterozygote | |
| Exon16 Met1736Val | Homozygote atg → gtg | Homozygote | Homozygote | Heterozygote | Heterozygote |
| Exon25 Asp2194Gly | Heterozygote gat → ggt | heterozygote | Heterozygote | ||
| Clinical presentation | |||||
| Age | 19 | 20 | 51 | 44 | |
| Clinical symptoms | Easy bruising | 1. Easy bruising 2. Postpartum hemorrhage | No bleeding episode | No bleeding episode | |
| Factor V activity, % (50–150%) | 3.2% | 2% | 58% | 54% | |
| PT: sec (range: 8–12) | 22.2 | 13.7 | 10.2 | 10.4 | |
| APTT: sec (range: 25.0–31.3) | 53.2 | 33.8 | 30.5 | 31.0 |
Patient 1 and 2 both had the same clinical symptoms and the Factor V activity.
PT, Prothrombin time; APTT, Activated partial thromboplastin time.